Stay updated on Olaparib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry was added (v3.6.5) replacing the previous v3.6.4 in the history, indicating a small update to the page’s backend or presentation rather than study data.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, signaling a backend software version update. The change does not affect the study history content or any visible data on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedThe record history now lists Revision: v3.6.3 as the latest entry, replacing the previous v3.6.2. This reflects a new site revision entry in the page's history.SummaryDifference0.0%

- Check51 days agoChange DetectedNew navigation items and section labels were added to the study record history page, including Compare and sections like Study Design, Study Status, Recruitment Status, Study Identification, IPDSharing, References, and Contacts/Locations, with corresponding version dates.SummaryDifference100%

- Check66 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study has stopped enrolling. A new revision tag (v3.6.0) was added, replacing the previous revision (v3.5.5).SummaryDifference0.1%

- Check73 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, signaling a minor update to the site’s version label.SummaryDifference0.0%

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.